Occurrence and a screening-level risk assessment of human pharmaceuticals in the pearl river system, South China

Jian Liang Zhao, Guang Guo Ying, You Sheng Liu, Feng Chen, Ji Feng Yang, Li Wang, Xiao Bing Yang, Jenny L. Stauber, Michael St J. Warne

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Ten nonsteroidal antiinflammatory drugs (NSAIDs), two blood lipid regulators (BLRs), and two antiepileptic drugs (AEDs) were analyzed in the Pearl River system in China (i.e., Liuxi, Zhujiang, and Shijing Rivers) and four sewage effluents during the dry and wet seasons, and the environmental risks they posed were assessed. Eight pharmaceuticals were detected in the rivers and effluents, including five NSAIDs (salicylic acid, ibuprofen, diclofenac, mefenamic acid, and naproxen), two BLRs (clofibric acid and gemfibrozil), and one AED (carbamazepine). The median concentrations for the eight pharmaceuticals ranged from 11.2 to 102 ng/L. Seasonal variations were not obvious for most pharmaceuticals in the three rivers, except for salicylic acid and clofibric acid in the Zhujiang River, and diclofenac in the Zhujiang and Shijing Rivers. However, spatially considerable variations in the concentrations were observed for the eight pharmaceuticals in all three rivers. For most of the pharmaceuticals, the effluents from the four wastewater treatment plants and Shijing River water were found to be the major discharge sources for the Zhujiang River, but with additional discharge sources from some small urban streams in the wet season. Diclofenac in the Shijing River was the only pharmaceutical that had a risk quotient (RQ) >1, indicating a high risk to aquatic organisms in the river. Although higher RQs were calculated for the mixture of the pharmaceuticals in each river, the risk rating remained the same for the three rivers with the RQ being >1 only in Shijing River. Environ. Toxicol. Chem. 2010;29:1377-1384.

Original languageEnglish
Pages (from-to)1377-1384
Number of pages8
JournalEnvironmental Toxicology and Chemistry
Volume29
Issue number6
DOIs
Publication statusPublished - 14 May 2010
Externally publishedYes

Fingerprint

Rivers
Risk assessment
river system
China
Screening
drug
risk assessment
river
Pharmaceutical Preparations
Diclofenac
Clofibric Acid
salicylic acid
Effluents
effluent
Salicylic Acid
wet season
screening
acid
Discharge (fluid mechanics)
Anticonvulsants

Keywords

  • Diclofenac
  • Pearl River
  • Pharmaceuticals
  • Risk quotient
  • Surface water

ASJC Scopus subject areas

  • Environmental Chemistry
  • Health, Toxicology and Mutagenesis

Cite this

Occurrence and a screening-level risk assessment of human pharmaceuticals in the pearl river system, South China. / Zhao, Jian Liang; Ying, Guang Guo; Liu, You Sheng; Chen, Feng; Yang, Ji Feng; Wang, Li; Yang, Xiao Bing; Stauber, Jenny L.; Warne, Michael St J.

In: Environmental Toxicology and Chemistry, Vol. 29, No. 6, 14.05.2010, p. 1377-1384.

Research output: Contribution to journalArticle

Zhao, Jian Liang ; Ying, Guang Guo ; Liu, You Sheng ; Chen, Feng ; Yang, Ji Feng ; Wang, Li ; Yang, Xiao Bing ; Stauber, Jenny L. ; Warne, Michael St J. / Occurrence and a screening-level risk assessment of human pharmaceuticals in the pearl river system, South China. In: Environmental Toxicology and Chemistry. 2010 ; Vol. 29, No. 6. pp. 1377-1384.
@article{6f9e32f0e3364a05866cf3f6d2790b85,
title = "Occurrence and a screening-level risk assessment of human pharmaceuticals in the pearl river system, South China",
abstract = "Ten nonsteroidal antiinflammatory drugs (NSAIDs), two blood lipid regulators (BLRs), and two antiepileptic drugs (AEDs) were analyzed in the Pearl River system in China (i.e., Liuxi, Zhujiang, and Shijing Rivers) and four sewage effluents during the dry and wet seasons, and the environmental risks they posed were assessed. Eight pharmaceuticals were detected in the rivers and effluents, including five NSAIDs (salicylic acid, ibuprofen, diclofenac, mefenamic acid, and naproxen), two BLRs (clofibric acid and gemfibrozil), and one AED (carbamazepine). The median concentrations for the eight pharmaceuticals ranged from 11.2 to 102 ng/L. Seasonal variations were not obvious for most pharmaceuticals in the three rivers, except for salicylic acid and clofibric acid in the Zhujiang River, and diclofenac in the Zhujiang and Shijing Rivers. However, spatially considerable variations in the concentrations were observed for the eight pharmaceuticals in all three rivers. For most of the pharmaceuticals, the effluents from the four wastewater treatment plants and Shijing River water were found to be the major discharge sources for the Zhujiang River, but with additional discharge sources from some small urban streams in the wet season. Diclofenac in the Shijing River was the only pharmaceutical that had a risk quotient (RQ) >1, indicating a high risk to aquatic organisms in the river. Although higher RQs were calculated for the mixture of the pharmaceuticals in each river, the risk rating remained the same for the three rivers with the RQ being >1 only in Shijing River. Environ. Toxicol. Chem. 2010;29:1377-1384.",
keywords = "Diclofenac, Pearl River, Pharmaceuticals, Risk quotient, Surface water",
author = "Zhao, {Jian Liang} and Ying, {Guang Guo} and Liu, {You Sheng} and Feng Chen and Yang, {Ji Feng} and Li Wang and Yang, {Xiao Bing} and Stauber, {Jenny L.} and Warne, {Michael St J.}",
year = "2010",
month = "5",
day = "14",
doi = "10.1002/etc.161",
language = "English",
volume = "29",
pages = "1377--1384",
journal = "Environmental Toxicology and Chemistry",
issn = "0730-7268",
publisher = "Wiley",
number = "6",

}

TY - JOUR

T1 - Occurrence and a screening-level risk assessment of human pharmaceuticals in the pearl river system, South China

AU - Zhao, Jian Liang

AU - Ying, Guang Guo

AU - Liu, You Sheng

AU - Chen, Feng

AU - Yang, Ji Feng

AU - Wang, Li

AU - Yang, Xiao Bing

AU - Stauber, Jenny L.

AU - Warne, Michael St J.

PY - 2010/5/14

Y1 - 2010/5/14

N2 - Ten nonsteroidal antiinflammatory drugs (NSAIDs), two blood lipid regulators (BLRs), and two antiepileptic drugs (AEDs) were analyzed in the Pearl River system in China (i.e., Liuxi, Zhujiang, and Shijing Rivers) and four sewage effluents during the dry and wet seasons, and the environmental risks they posed were assessed. Eight pharmaceuticals were detected in the rivers and effluents, including five NSAIDs (salicylic acid, ibuprofen, diclofenac, mefenamic acid, and naproxen), two BLRs (clofibric acid and gemfibrozil), and one AED (carbamazepine). The median concentrations for the eight pharmaceuticals ranged from 11.2 to 102 ng/L. Seasonal variations were not obvious for most pharmaceuticals in the three rivers, except for salicylic acid and clofibric acid in the Zhujiang River, and diclofenac in the Zhujiang and Shijing Rivers. However, spatially considerable variations in the concentrations were observed for the eight pharmaceuticals in all three rivers. For most of the pharmaceuticals, the effluents from the four wastewater treatment plants and Shijing River water were found to be the major discharge sources for the Zhujiang River, but with additional discharge sources from some small urban streams in the wet season. Diclofenac in the Shijing River was the only pharmaceutical that had a risk quotient (RQ) >1, indicating a high risk to aquatic organisms in the river. Although higher RQs were calculated for the mixture of the pharmaceuticals in each river, the risk rating remained the same for the three rivers with the RQ being >1 only in Shijing River. Environ. Toxicol. Chem. 2010;29:1377-1384.

AB - Ten nonsteroidal antiinflammatory drugs (NSAIDs), two blood lipid regulators (BLRs), and two antiepileptic drugs (AEDs) were analyzed in the Pearl River system in China (i.e., Liuxi, Zhujiang, and Shijing Rivers) and four sewage effluents during the dry and wet seasons, and the environmental risks they posed were assessed. Eight pharmaceuticals were detected in the rivers and effluents, including five NSAIDs (salicylic acid, ibuprofen, diclofenac, mefenamic acid, and naproxen), two BLRs (clofibric acid and gemfibrozil), and one AED (carbamazepine). The median concentrations for the eight pharmaceuticals ranged from 11.2 to 102 ng/L. Seasonal variations were not obvious for most pharmaceuticals in the three rivers, except for salicylic acid and clofibric acid in the Zhujiang River, and diclofenac in the Zhujiang and Shijing Rivers. However, spatially considerable variations in the concentrations were observed for the eight pharmaceuticals in all three rivers. For most of the pharmaceuticals, the effluents from the four wastewater treatment plants and Shijing River water were found to be the major discharge sources for the Zhujiang River, but with additional discharge sources from some small urban streams in the wet season. Diclofenac in the Shijing River was the only pharmaceutical that had a risk quotient (RQ) >1, indicating a high risk to aquatic organisms in the river. Although higher RQs were calculated for the mixture of the pharmaceuticals in each river, the risk rating remained the same for the three rivers with the RQ being >1 only in Shijing River. Environ. Toxicol. Chem. 2010;29:1377-1384.

KW - Diclofenac

KW - Pearl River

KW - Pharmaceuticals

KW - Risk quotient

KW - Surface water

UR - http://www.scopus.com/inward/record.url?scp=77953559053&partnerID=8YFLogxK

U2 - 10.1002/etc.161

DO - 10.1002/etc.161

M3 - Article

VL - 29

SP - 1377

EP - 1384

JO - Environmental Toxicology and Chemistry

JF - Environmental Toxicology and Chemistry

SN - 0730-7268

IS - 6

ER -